Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain
Clinical trial NCT01885182 · COMPLETED
Trial details
- NCT number
- NCT01885182
- Sponsor
- Mundipharma (China) Pharmaceutical Co. Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2015-08-30
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.